Shopping Cart 0
Cart Subtotal
USD 0

Herantis Pharma Plc (HRTIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Herantis Pharma Plc (Herantis Pharma) is a drug development company that offers regenerative medicine for neurodegenerative diseases. The company's pipeline products include CDNF for amyotrophic lateral sclerosis, CDNF for Parkinson's disease and lymfactin for secondary lymphedema. Its lymfactin recovers the damaged lymph system by reconstituting lymphatic vasculature. Herantis Pharma offers CDNF for disease modification in neurodegenerative diseases such as Parkinson's and ALS. The company develops drug candidates through late pre-clinical and early clinical stages. It partners with pharmaceutical and biotech companies. Herantis Pharma is headquartered in Espoo, Finland.

Herantis Pharma Plc (HRTIS)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Herantis Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Herantis Pharma Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Herantis Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Herantis Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Herantis Pharma Plc, Medical Devices Deals, 2012 to YTD 2018 9

Herantis Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Herantis Pharma Plc, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Herantis Pharma Enters into Agreement with Renishaw 11

Merger 12

Hermo Pharma Merges with Laurantis Pharma 12

Licensing Agreements 13

Herantis Pharma Enters into Licensing Agreement with University of Helsinki 13

Equity Offering 14

Herantis Pharma Plans to Raise up to USD5.4 Million in Private Placement of Shares 14

Herantis Pharma Raises USD0.3 Million in Private Placement of Shares 15

Herantis Pharma Raises USD20 Million in IPO 16

Herantis Pharma Plc-Key Competitors 17

Herantis Pharma Plc-Key Employees 18

Herantis Pharma Plc-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 20

Financial Announcements 20

Aug 29, 2018: Herantis Pharma's half year financial report January 1-June 30, 2018 20

Mar 02, 2018: Herantis Pharma Financial Statements Release January 1-December 31, 2017 24

Aug 29, 2017: Herantis Pharma: half year financial report January 1-June 30, 2017 27

Feb 28, 2017: Herantis Pharma Financial Statements Release January 1-December 31, 2016 31

Government and Public Interest 34

Apr 19, 2018: Herantis Pharma awarded Innovation prize of the Chemical Industry Federation of Finland 34

Product News 35

06/22/2017: Herantis Pharmas Lymfactin study advances to last patient cohort, company announces initial plans for continued development 35

02/12/2018: Herantis Pharma strengthens team-Outi Lahdenpera and Antti Vuolanto have joined Herantis 36

Clinical Trials 37

Jun 13, 2018: Herantis Pharma announces initiation of Phase 2 study for Lymfactin gene therapy in secondary lymphedema 37

Apr 16, 2018: Herantis Pharma announces positive interim data from Lymfactin study in secondary lymphedema 38

Feb 08, 2018: Herantis Pharma completes patient enrolment in Phase 1 study of Lymfactin gene therapy for secondary lymphedema and has submitted Phase 2 application 39

Dec 27, 2017: Herantis Pharma expands on timeline for Lymfactin studies 40

Mar 06, 2017: Herantis Pharma's clinical study with Lymfactin advances to high dose level 41

Appendix 42

Methodology 42

About GlobalData 42

Contact Us 42

Disclaimer 42


List Of Figure

List of Figures

Herantis Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Herantis Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Herantis Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Herantis Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Herantis Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Herantis Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Herantis Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Herantis Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Herantis Pharma Plc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Herantis Pharma Plc, Pharmaceuticals & Healthcare, Key Facts 2

Herantis Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Herantis Pharma Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Herantis Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Herantis Pharma Plc, Deals By Therapy Area, 2012 to YTD 2018 8

Herantis Pharma Plc, Medical Devices Deals, 2012 to YTD 2018 9

Herantis Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Herantis Pharma Enters into Agreement with Renishaw 11

Hermo Pharma Merges with Laurantis Pharma 12

Herantis Pharma Enters into Licensing Agreement with University of Helsinki 13

Herantis Pharma Plans to Raise up to USD5.4 Million in Private Placement of Shares 14

Herantis Pharma Raises USD0.3 Million in Private Placement of Shares 15

Herantis Pharma Raises USD20 Million in IPO 16

Herantis Pharma Plc, Key Competitors 17

Herantis Pharma Plc, Key Employees 18

Herantis Pharma Plc, Other Locations 19

Herantis Pharma Plc, Subsidiaries 19

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Herantis Pharma Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.